On Friday, Following U.S. Stocks were among the “Top Gainers”:Levy Acquistion (NASDAQ:LEVY), RXi Pharmaceuticals (NASDAQ:RXII), InspireMD (NYSEMKT:NSPR), Media General (NYSE:MEG)

Levy Acquistion Corp (NASDAQ:LEVY), with shares inclined 3.70%, closed at $10.64, hitting new 52-week high of $10.81.

RXi Pharmaceuticals Corp (NASDAQ:RXII), with shares jumped 3.60%, settled at $1.15.

InspireMD Inc (NYSEMKT:NSPR), with shares climbed 3.45%, and closed at $0.300.

Media General Inc (NYSE:MEG), surged 3.42%, and closed at $16.02.

Latest NEWS regarding these Stocks are depicted underneath:

Levy Aquisition Corp. (NASDAQ:LEVY)

Del Taco Holdings, Inc. the second largest Mexican-American QSR chain by units in the United States, operating restaurants under the name Del Taco®, and Levy Attainment Corp. (LEVY), declared that they have reached a definitive merger contract whereby Del Taco will become the sole direct partner of LAC. Right away following the Merger, LAC intends to change its name to Del Taco Restaurants, Inc. and will continue to trade on the NASDAQ stock exchange.

Preceding to the Merger, Restaurateur Larry Levy’s family and other new investors (“LLI”) will make a private investment of $120 million in the equity of Del Taco. Upon the closing of LLI’s equity investment and preceding to Del Taco’s Merger with LAC, Mr. Levy will become Chairman of the Del Taco Board of Directors and partner with administration to oversee the Corporation’s growth and brand building. The LLI purchase price is based on a $500 million enterprise value for Del Taco, not including transaction costs.

At the Merger, a partner of LAC will merge into Del Taco so that Del Taco becomes a wholly-owned partner of LAC. LAC will attain Del Taco at the same implied enterprise value as that reflected in LLI’s purchase price. The completion of the projected business combination is subject to LAC stockholder approval and a limited number of other closing conditions. LAC anticipates the Merger will be accomplished in June 2015.

Levy Attainment Corp. does not have noteworthy operations. It intends to complete a business combination with an operating corporation in the restaurant and hospitality sectors. In November 2013, LAC consummated its initial public offering of 15 million units, each unit comprising of one share of ordinary stock and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of ordinary stock at a price of $11.50 per share. Aggregate proceeds of $150,000,000 from the IPO were placed in trust pending completion of LAC’s initial business combination.

RXi Pharmaceuticals Corporation (NASDAQ:RXII)

RXi Pharmaceuticals Corporation (RXII), a biotechnology corporation focused on discovering and developing innovative therapeutics, that address high-unmet medical needs primarily in the area of dermatology and ophthalmology, recently declared that the Corporation’s Vice President of Medical Affairs and Safety Assessment, Dr. Lyn Libertine will present at the 73rd Annual Meeting of the American Academy of Dermatology (AAD) on March 23, 2015 in San Francisco, CA. This meeting will feature world-renowned leaders presenting the latest research in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail conditions.

RXi Pharmaceuticals Corporation, a biotechnology corporation, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform.

InspireMD, Inc. (NYSEMKT:NSPR)

InspireMD, Inc. (NSPR), a leader in stent embolic protection systems, declared its financial and operating results for the fourth quarter and year ended December 31, 2014.

Recent Operating Highlights:

Commercial

• Initiated a Limited Market Release (LMR) of CGuard.
• Resumed shipping of MGuard Prime into hospital accounts. Certain distribution partners also resumed MGuard Prime restocking with hospital customers following European approval of the manufacturing process changes.

REGULATORY / CLINICAL / PRODUCT DEVELOPMENT

Declared CE Mark approval for CGuard RX rapid exchange delivery system, a MicroNetTMcovered carotid stent technology.

Stated Six-Month Ultrasound Analysis from the CARENET study, which confirmed widely patent internal and external carotid arteries.

Successfully accomplished pre-clinical PK study with initial DES candidate with promising results.

Stated positive trends in mortality in the 30 day results on the 310 patients enrolled in MASTER II, in addition to pooled data from MASTER II, and the 433 patient MASTER I trial accomplished and published in 2012.

FINANCIAL

• Strengthened cash position with the completion of financing on November 7th, 2014, with gross proceeds of $8.1 million and March 9th, 2015 with gross proceeds of $13.7 million.
• Implemented cost containment activities, counting measures to significantly reduce the burn rate throughout 2015.

InspireMD, Inc., a medical device corporation, focuses on the development and commercialization of proprietary MGuard stent platform technology. Its MGuard stent is an embolic protection device based on a protective sleeve, which is constructed out of an ultra-thin polymer mesh and wrapped around the stent.

Media General, Inc. (NYSE:MEG)

Media General, Inc. (MEG), one of the nation’s largest cross-screen media companies, declared that Richard Levine has been designated Head of Distribution.

Mr. Levine is an accomplished television distribution executive who specializes in contract negotiations; content creation, attainment and distribution; planned planning and new business development through partnerships and other proceed generating opportunities.

Most recently, Mr. Levine was Vice President of Content for AT&T Services. In that role, he oversaw strategy and content attainment for national cable networks and broadcast networks. As an integral member of the team that launched AT&T U-Verse, Mr. Levine successfully developed content distribution and negotiated partnerships with major media companies for retransmission and licensing of content on AT&T‘s Uverse television, mobile and broadband platforms. Preceding to AT&T Services, he was in Programming Attainments at DIRECTV, where he attained rights from broadcast networks, pay-per-view television and movies.

In his new role that reports to Media General’s President and CEO Vincent L. Sadusky, Mr. Levine oversees all aspects of content distribution and negotiations with Multichannel Video Program Distributors and major media companies for retransmission and licensing of the Corporation’s highly consumed multiscreen content. In addition, he is responsible for business development opportunities to drive profitable proceed growth. He will work closely with regulatory authorities and other industry leaders to assist ensure a successful future for Media General and the industry as a whole.

Media General is one of the nation’s largest cross-screen, multimedia companies that operates or services 71 television stations in 48 markets together with the industry’s leading digital media business. Media General has the industry’s largest and most diverse digital media business with a growing portfolio that comprises LIN Digital, LIN Mobile, Federated Media, HYFN, Dedicated Media and BiteSizeTV.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.